ADAMTS13 and thrombotic thrombocytopenic purpura: Baseline severity, platelet count or time since TTP diagnosis did not appear to influence ADAMTS13 recovery (Table 2), but presence of inhibitor boosting did have an impact (discussed in inhibitor subanalysis section).